reconstitution raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-04-04. Anything still debated is marked as such rather than presented as settled.
Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.
Dry powder is commonly held at minus twenty degrees Celsius, with some suppliers recommending lower temperatures for long-term archival storage. Once dissolved, solutions are typically kept cold and protected from light, since aqueous peptide solutions can lose integrity through hydrolysis or oxidation over time. Stability data specific to this fragment are limited in the public literature, and much of the guidance comes from general peptide handling practice rather than from controlled degradation studies. Users therefore treat stated shelf lives as approximate rather than fixed.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 0.9 kDa | Depends on exact fragment sequence and counterion |
| Amino acid sequence | LKKTETQ (commonly cited) | Short actin-binding motif from thymosin beta-4 |
| Common salt form | Acetate salt | Trifluoroacetate also reported in research material |
| Reconstitution solvent | Sterile water or buffer | Gentle mixing; avoid vigorous agitation |
| Solution storage | -20 °C or lower | Aliquot to avoid repeated freeze-thaw cycles |
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
Union of Sovereign States: The treaty proposed to set up a Union of Sovereign and Equal States based on democracy and rule-of-law as successor to the Union of Soviet Socialist Republics. This new polity was envisioned as a voluntary association of sovereign republics with a common federal government. A member joins the Union either directly or as a part of other states, and relations between members when one of them is a part of another are regulated by treaties between them. Presidential Council: The treaty proposed the creation of a Presidential Council that would consist of the leaders of the republics and the president of the Union. This council would be responsible for making important decisions and coordinating policies at federal level. A Union Constitutional Court would be created to settle disputes over questions of the exercise of the powers of Union organs. The legislative power of the Union would be exercised by the USSR Supreme Soviet, which consists of two chambers: the Soviet of the Republics, elected by the population of the whole country, and the Soviet of the Union. Decentralization of Power: The treaty aimed to decentralize political power by granting greater autonomy to the Republics giving them general guarantees about the right to control their own resources and legislate including the right to freely secede from the Union. Division of Powers: The central government would handle issues of defence, foreign affairs, financial system, energy resources and overall coordination along with issuing its currency.
=== LeukoSite === Springer has played a prominent role in biotechnology. His scientific and entrepreneurial work has contributed to multiple FDA-approved therapies in immunology, oncology, and rare diseases, and he has been an influential early investor and company founder in the life sciences industry. In the early 1990s, Springer founded LeukoSite to develop therapeutics based on leukocyte adhesion and trafficking biology. LeukoSite’s programs advanced or incorporated three agents that ultimately became approved medicines: vedolizumab (Entyvio), a humanized antibody targeting integrin α4β7 for inflammatory bowel disease; bortezomib (Velcade) for multiple myeloma and mantle cell lymphoma; and alemtuzumab (Campath-1/Lemtrada) for B-cell chronic lymphocytic leukemia and multiple sclerosis. Millennium Pharmaceuticals acquired LeukoSite in late 1999 by issuing shares; after the merger, LeukoSite shareholders owned 35% of Millennium stock. LeukoSite’s antibody program targeting integrin α4β7 was the foundation for vedolizumab (Entyvio), approved by the FDA in 2014 for ulcerative colitis and Crohn’s disease. Entyvio has since become a major product in the immunology space: Takeda, which acquired the asset through its purchase of Millennium, reported Entyvio revenue of JPY 914.1 billion, approximately US$6.1 billion, for the fiscal year ended March 31, 2025. More than 350,000 patients have been treated with Entyvio since 2014 in the U.S., based on Symphony claims data (June 2014-Jan 2025). Takeda has described Entyvio as a cornerstone of its portfolio.
Mass spectrometry has been successfully used to identify changes in the composition of the adhesome upon perturbation. Schiller et al. as well as Kuo et al. examined the effect of inhibition of myosin contractility on the integrin adhesome composition and found LIM domain proteins and beta-PIX to be tension sensitive. Gou et al. found little change in the cadherin adhesome after calcium depletion from the media, which essentially abrogates cell-cell adhesion. Reinhard Fassler and co-workers used proteomics on specifically engineered cell lines to distinguish between the adhesome of β1- and αv-class integrins.
=== Pregnancy === The research into the safety of benzodiazepines during pregnancy is limited and it is recommended that use of benzodiazepines during pregnancy should be based on whether the benefits outweigh the risks. If chlordiazepoxide is used during pregnancy, the risks can be reduced via using the lowest effective dose and for the shortest time possible. Benzodiazepines should generally be avoided during the first trimester of pregnancy. Chlordiazepoxide and diazepam are considered to be among the safer benzodiazepines to use during pregnancy in comparison to other benzodiazepines. Possible adverse effects from benzodiazepine use during pregnancy include miscarriage, malformation, intrauterine growth retardation, functional deficits, carcinogenesis and mutagenesis. Caution is also advised during breast feeding as chlordiazepoxide passes into breast milk.
Sources: en.wikipedia.org
The Mareth Line constituted one of two fronts in the Tunisia Campaign, the second being to the north-west, where the British First Army and American II Corps, firmly established in formerly Vichy-held Morocco and Algeria following Operation Torch in November 1942, were gradually pushing the Axis forces under Hans-Jürgen von Arnim back towards Tunis. After von Arnim won a decisive victory over the Americans at the Battle of Sidi Bou Zid in mid-February 1943, destroying over 100 US tanks, the Eighteenth Army Group was formed under the British General Harold Alexander to co-ordinate the actions of the Allied forces on both Tunisian fronts. The Eighth Army under Montgomery spent February at Medinine in south-eastern Tunisia. Expecting an imminent attack by the Axis, the Eighth Army mustered every anti-tank gun it could from Egypt and Libya. The 102nd (Northumberland Hussars) Anti-Tank Regiment, including the Rhodesian Anti-Tank Battery under Major Savory, duly advanced west from Benghazi and reached the front on 5 March 1943. The Germans and Italians assaulted Medinine the next day, but failed to make much progress and abandoned their attack by the evening. The Rhodesian gunners, held in reserve, did not take part in the engagement but were attacked from the air. The Rhodesians of the KRRC, now under the 7th Motor Brigade, moved up from Libya during early March. No. 237 (Rhodesia) Squadron, which had spent 1942 and the first months of 1943 in Iran and Iraq, returned to North Africa the same month, with the future Prime Minister Ian Smith in its ranks as a Hurricane pilot.
=== Cell turnover === Fat cells in some mice have been shown to drop in count due to fasting and other properties were observed when exposed to cold. If the adipocytes in the body reach their maximum capacity of fat, they may replicate to allow additional fat storage.
==== Conditions for higher transfer results ==== Nearly complete transfer in systems implementing countercurrent exchange, is only possible if the two flows are, in some sense, "equal". For a maximum transfer of substance concentration, an equal flowrate of solvents and solutions is required. For maximum heat transfer, the average specific heat capacity and the mass flow rate must be the same for each stream. If the two flows are not equal, for example if heat is being transferred from water to air or vice versa, then, similar to cocurrent exchange systems, a variation in the gradient is expected because of a buildup of the property not being transferred properly.
Javits (1952), former ambassador and permanent U.S. representative to the Conference on Disarmament in Geneva 2001–2003; U.S. permanent representative to the Organisation for the Prohibition of Chemical Weapons 2003–2009 James D. Theberge (1952), former U.S. ambassador to Chile and Nicaragua G. Norman Anderson (1954), former U.S. ambassador to Sudan David J. Bardin (1954), deputy administrator of the Federal Energy Administration; commissioner of the New Jersey Department of Environmental Protection William Haddad (1954), political operative, lobbyist, and journalist, Peace Corps founding official, aide to the Kennedy family, and grandson-in-law of Franklin D. Roosevelt Richard E. Benedick (1955), president emeritus of the National Council for Science and the Environment, ambassador, and chief U.S. negotiator to the Montreal Protocol John L. Hirsch (1957), U.S. ambassador to Sierra Leone 1995–1998 Morton Halperin (1958), deputy assistant secretary of defense, director of policy planning for the U.S. State Department, and member of Richard Nixon's Enemies List Shelby Brewer (1959), assistant secretary of energy for nuclear energy 1981–1984 Benjamin Huberman (1959), acting director of the Office of Science and Technology Policy; acting science advisor to the president in 1981 Pat Mullins (1959), chairman of the Republican Party of Virginia Constantine Menges (1960), national security aide to Ronald Reagan James E.
=== 1950s onward === The advent in the 1950s of fibrous synthetics such as nylon, polyethylene, polypropylene, and polyvinyls provided new materials from which researchers and doctors in the field of wound care could explore better protecting of healing wounds and even accelerating the natural wound healing process. In the 1960s, research and articles by George Winter and Howard Maibach reported on the superior efficacy of moist wound dressings. The adoption of moist wound dressing technique as recommended best wound dressing practice reflected a large advance in approach producing markedly superior clinical outcomes. This dawn of modern wound care treatment initiated a process of improvement in the clinician's ability to bolster wound-site re-epithelialization and healing. The focus on evidence-based best practices and research continues. In the 1990s, improvements in composite and hybrid polymers expanded the range of materials available for wound dressing. Grafting and biotechnology have produced usable and useful protective covering of actual human skin generated through cloning procedures. These improvements, coupled with the developments in tissue engineering, have given rise to a number of new classes of wound dressings. One of these, "living skin equivalents," is often cited as a misnomer because they lack key components of whole living skin. "Living skin equivalents" may have the potential to serve as cellular platforms for the release of growth factors essential for proper wound healing.
Sources: en.wikipedia.org
Dry lyophilized powder is usually kept frozen, desiccated, and out of direct light. Sealed vials are not opened until needed, because moisture uptake can degrade short peptides. Longer archival storage is often done at lower temperatures than routine working stock.
Reversed-phase liquid chromatography separates components and reports purity from peak area. Mass spectrometry confirms the molecular mass expected for the sequence. Additional approaches such as peptide mapping or amino acid analysis provide independent confirmation.
Reported percentages depend on the analytical method, the detection wavelength, and whether salts and water are counted. A value above ninety-five percent by chromatography does not by itself establish a correct sequence. Different suppliers also calculate purity against different reference standards.
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.